On June 26, 2025, Crinetics Pharmaceuticals hosted an R&D Day to share updates on its drug development pipeline, including promising preclinical data on treatments for Graves' disease and autosomal dominant polycystic kidney disease. The event highlighted key developments in their early-stage pipeline assets and future clinical strategies.